F886 in New York. Pick another state for the same tag.
Against expectation — 2023
New York cites F886 less often than its own record predicts
Versus expected share0.66×
0.66 times the national share — cited less often here than elsewhere.
Share of New York citations0.05%
Of every deficiency written in New York in 2023, this is the portion that was F886.
New York0.05%
National0.08%
Share of all citations that were F886.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What New York surveyors wrote
F886 findings written in New York, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedJanuary 13, 2023
Based on interview and record review during the Recertification Survey and Abbreviated Survey (NY00306893) initiated on 1/5/2023 and completed on 1/13/2023, the facility did not conduct COVID-19 testing individuals with known or suspected exposure to COVID-19. This was identified for one (Resident #263) of one resident reviewed for Infection Control. Specifically, Resident #263 was transferred to the hospital for low blood pressure, low heart rate and low oxygen saturation on 12/22/2022. At the hospital the resident was diagnosed with COVID-19 infection. The facility was notified of the resident's COVID-19 diagnosis by the hospital. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction